Decreased serum paraoxonase 1 activity and increased serum homocysteine and malondialdehyde levels in Age-related macular degeneration

Tohoku Journal of Experimental Medicine

Volumn 217, Issue 1, 2009, Pages 17-22

  Ates, Orhan ^a   Azzi, Sedat ^a   Alp, H Hakan ^a   Kiziltunc, Ahmet ^a   Beydemir, Sukru ^b   Cinici, Emine ^a   Kocer, Ibrahim ^a   Baykal, Orhan ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Age related macular degeneration; Homocysteine; Lipid peroxidation; Oxidative stress; Paraoxonase

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ENZYME; FREE RADICAL; HOMOCYSTEINE; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; ENDOTHELIUM INJURY; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SMOKING; SUBRETINAL NEOVASCULARIZATION; VASCULAR ENDOTHELIUM; VISUAL IMPAIRMENT;

EID: 63049137465     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.217.17     Document Type: Article

References (48)

1. Alvares Delfino, V.D., de Andrade Vianna, A.C., Mocelin, A.J., Barbosa, D.S., Mise, R.A. & Matsuo, T. (2007) Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients. Nutrition, 23, 242-247.
2. Axer-Siegel, R., Bourla, D., Ehrlich, R., Dotan, G., Benjamini, Y., Gavendo, S., Weinberger, D. & Sela, B.A. (2004) Association of neovascular age-related macular degeneration and hyperhomocysteinemia. Am. J. Ophthalmol., 137, 84-89.
3. Baskol, G., Karakucuk, S., Oner, AO., Baskol, M., Kocer D., Mirza E., Saraymen R. & Ustdal, M. (2006) Serum Paraoxonase 1 activity and peroxidation levels in patients with age-related macular degeneration. Ophthalmologica, 1, 12-16.
4. Baskol, G., Karakucuk, S., Oner, A., Ertugrul Mirza, G. & Kocer, D. (2004) Serum MDA and AOPP levels in age related macular degeneration. Erciyes Medical Journal, 26, 7-11.
5. Beatty, S., Koh, H., Phil, M., Henson, D. & Boulton, M. (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol., 45, 115-134.
6. Cohen, S.M., Olin, K.L., Feuer, W.J., Hjelmeland, L., Keen, C.L. & Morse, L.S. (1994) Low glutathione reductase and peroxidase activity in age-related macular degeneration. Br. J. Ophthalmol., 78, 791-794.
7. Delcourt, C., Cristol, J.P, Tessier, F., Leger, C.L., Descomps, B. & Papoz, L. (1999) Age-related macular degeneration and antioxidant status in the POLA study. Arch. Ophthalmol., 117, 1384-1390.
8. Desmettre, T., Lecerf, J.M. & Souied, E.H. (2004) Nutrition and age-related macular degeneration. J. Fr. Ophtalmol., 27, 38-56.
9. Drobek-Slowik, M., Karczewicz, D. & Safranow, K. (2007) The potential role of oxidative stress in the pathogenesis of the age-related macular degeneration (AMD). Postepy. Hig. Med. Dosw., 61, 28-37.
10. Evereklioglu, C., Er. H., Doganay, S., Cekmen, M., Turkoz, Y., Otlu, B. & Ozerol, E. (2003) Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration. Doc. Ophthalmol., 106, 129-136.
11. Feher, J., Kovacs, B., Kovacs, I., Schveoller, M., Papale, A. & Balacco-Gabrieli, C. (2005) Improvement of visual functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-L-Carnitine, n-3 fatty acids, and coenzyme Q10. Ophthalmologica, 219, 154-166.
12. Ferretti, G., Bacchetti, T., Masciangelo, S. & Pallotta, G. (2007) Lipid peroxidation in hemodialysis patients: Effect of vitamin C supplementation. Clin. Biochem., 41, 381-386.
13. 12 in patients with coronary heart disease. Ann. Nutr. Metab., 50, 413-419.
14. Gocmen, A.Y., Gumuslu, S. & Semiz, E. (2004) Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease. Clin. Cardiol., 27, 426-430.
15. Gocmen, Y.A., Semiz, E. & Gumuslu, S. (2005) Relationship between paraoxonase-1 (PON1) activity and lipoprotein (a) levels in Turkish coronary artery disease patients living in the Antalya region. Eur. J. Cardiovasc. Prev. Rehabil., 12, 185-186.
16. Halliwell, B. (1991) Reactive oxygen species in living system: source, biochemistry, and role in human disease. Am. J. Med., 91, 14-22.
17. Hankey, G.J. & Eikelboom, J.W. (1999) Homocysteine and vascular disease. Lancet, 354, 407-413.
18. Harangi, M., Seres, I., Magyar, M.T., Csipo, I., Sipka, S., Valikovics, A., Csiba, L., Bereczki, D. & Paragh, G. (2008) Association between human paraoxonase 1 activity and intima-media thickness in subjects under 55 years of age with carotid artery disease. Cerebrovasc. Dis., 25, 122-128.
19. Ikeda, T., Obayashi, H., Hasegawa, G., Nakamura, N., Yoshikawa, T., Imamura, Y., Koizumi, K. & Kinoshita, S. (2001) Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration. Am. J. Ophthalmol., 132, 191-195.
20. Irshad, M. & Chaudhuri, P.S. (2002) Oxidant-antioxidant system: role and significance in human body. Indian. J. Exp. Biol., 40, 1233-1239.
21. Isik, B., Ceylan, A. & Isik, R. (2007) Oxidative stress in smokers and non-smokers. Inhal. Toxicol., 19, 767-769.
22. Jakubowski H. (1997) Metabolism of homocysteine thiolactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels. J. Biol. Chem., 272, 1935-1942.
23. Jakubowski, H. (2003) Homocysteine thiolactone and S-nitrosohomocysteine mediate incorporation of homocysteine into protein in humans. Clin. Chem. Lab. Med., 41, 1462-1466.
24. Janel, N., Robert, K., Chabert, C., Ledru, A., Gouédard, C., Barouki, R., Delabar, J.M. & Chassé, J.F. (2004) Mouse liver paraoxonase-1 gene expression is downregulated in hyperhomocysteinemia. Thromb. Haemost., 92, 221-222.
25. Kamburoglu, G., Gumus, K., Kadayifcilar, S. & Eldem, B. (2006) Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol., 5, 565-569.
26. Kaemmerer, E., Schutt, F., Krohne, T.U., Holz, F.G. & Kopitz, J. (2007) Effects of lipid peroxidation-related protein modifications on RPE lysosomal functions and POS phagocytosis. Invest. Ophthalmol. Vis. Sci., 3, 1342-1347.
27. Kamei, M., Yoneda, K., Kume, N., Suzuki, M., Itabe, H., Matsuda, K., Shimaoka, T., Minami, M., Yonehara, S., Kita, T. & Kinoshita S. (2007) Scavenger receptors for oxidized lipoprotein in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci., 48, 1801-1807.
28. Leibovitz, B.E. & Siegel, B.V. (1980) Aspects of free radical reactions in biological systems. Aging. J. Gerontol., 35, 45-56.
29. Marchegiani, F., Marra, M., Olivieri, F., Cardelli, M., James, R.W., Boemi, M. & Franceschi C. (2008) Paraoxonase 1: genetics and activities during aging. Rejuvenation Res., 11, 113-127.
30. Nowak, J.Z. (2006) Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol. Rep., 58, 353-363.
31. Nowak, M., Swietochowska, E., Wielkoszyński, T., Marek, B., Kos-Kudła, B., Szapska, B., Kajdaniuk, D., Głogowska-Szelág, J., Siemińska, L., Ostrowska, Z., Kozioł, H. & Klimek, J. (2005a) Homocysteine, vitamin B12, and folic acid in age-related macular degeneration. Eur. J. Ophthalmol., 15, 764-767.
32. Nowak, M., Gnitecki, W. & Jurowski, P. (2005b) The role of retinal oxygen metabolism in origin of age-related macular degeneration (AMD). Klin. Oczna., 107, 715-718.
33. Ohira, A., Ueda, T., Ohishi, K., Hiramitsu, T., Akeo, K. & Obara, Y. (2008) Oxidative stress in ocular disease. Nippon Ganka Gakkai Zasshi, 112, 22-29.
34. Ozdemir, R., Barutcu, I., Sezgin, A.T., Acikgoz, N., Ermis, N., Esen, A.M., Topal, E., Bariskaner, E. & Ozerol I. (2004) Vascular endothelial function and plasma homocysteine levels in Behcet's disease. Am. J. Cardiol., 94, 522-525.
35. Papandreou, D., Mavromichalis, I., Makedou, A., Rousso, I. & Arvanitidou, M. (2006) Total serum homocysteine, folate and vitamin B12 in a Greek school age population. Clin. Nutr., 25, 797-802.
36. Papatheodorou, L. & Weiss, N. (2007) Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid. Redox Signal., 9, 1941-1958.
37. Stamler, J.S., Osborne, J.A., Jaraki, O., Rabbani, L.E., Mullins, M., Singel, D. & Loscalzo, J. (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J. Clin. Invest., 91, 308-318.
38. Seddon, J.M., Ajani, U.A., Sperduto, R.D., Hiller, R., Blair, N., Burton, T.C., Farber, M.D., Gragoudas, E.S., Haller, J. & Miller, D.T. (1994) Dietry carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA., 272, 1413-1421.
39. Seddon, J.M., Gensler, G., Klein, M.L. & Milton, R.C. (2006) Evaluation of plasma homocysteine and risk of age-related macular degeneration. Am. J. Ophthalmol., 1, 201-203.
40. Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T., Mazur, M. & Telser, J. (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell. Biol., 39, 44-84.
41. Van Leeuwen, R., Klaver, C.C., Vingerling, J.R., Hofman, A. & de Jong, P.T. (2003) The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch. Ophthalmol., 121, 519-526.
42. Vingerling, J.R., Dielemans, I., Bots, M.L., Hofman, A., Grobbee, D.E. & de Jong, P.T. (1995) Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am. J. Epidemiol., 142, 404-409.
43. Vingerling, J.R., Hofman, A., Grobbee, D.E. & de Jong, P.T. (1996) Age-related macular degeneration and smoking. The Rotterdam Study. Arch. Ophthalmol., 114, 1193-1196.
44. Wiggs, J.L. (2007) Macular degeneration: risk factors for progression. Arch. Ophthalmol., 125, 1264-1265.
45. Winkler, B.S., Boulton, M.E., Gottsch, J.D. & Sternberg, P. (1999) Oxidative damage and age-related macular degeneration. Mol. Vis., 5, 32.
46. Ueland, P.M., Refsum, H., Stabler, S.P., Malinow, M.R., Andersson, A. & Allen, R.H. (1993) Total homocysteine in plasma or serum: methods and clinical applications. Clin. Chem., 39, 1764-1779.
47. Upchurch, G.R. Jr., Welch, G.N., Fabian, A.J., Freedman, J.E., Johnson, J.L., Keaney,. JF. Jr. & Loscalzo, J. (1997) Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J. Biol. Chem., 272, 17012-17017.
48. Young, R.W. (1998) Solar radiation and age-related macular degeneration. Surv. Ophthalmol., 32, 252-269.